RHOC and ovarian carcinoma: Furthermore, overexpression of miR-93-5P inhibited tumorigenesis and progression via targeting RhoC in epithelial ovarian cancer (OVCAR3, SKOV3/DDP, HO8910-PM) cells and OVCAR3 xenografts [214].